天迈科技：10月24日召开董事会会议

Group 1 - The core point of the article is that Tianmai Technology (SZ 300807) held its 13th board meeting on October 24, 2025, to review the agenda including the third-quarter report for 2025 [1] - For the year 2024, Tianmai Technology's revenue composition is entirely from intelligent transportation, accounting for 100.0% [1] - As of the report, Tianmai Technology has a market capitalization of 2.7 billion yuan [1] Group 2 - The article mentions that Chinese innovative drugs have generated 80 billion USD in overseas licensing this year [1] - There is a discussion on the hot secondary market for biomedicine, while the primary market is facing challenges in fundraising [1]